NUP214-ABL1阳性T细胞急性淋巴细胞白血病患者复发后对伊马替尼治疗显示出初步良好反应。 - Suppr

Suppr

超能文献

NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse.

作者信息

Clarke Sarah, O'Reilly John, Romeo Giuliana, Cooney Julian

出版信息

Leuk Res. 2011 Jul;35(7):e131-3. doi: 10.1016/j.leukres.2011.03.025. Epub 2011 Apr 13.

DOI:10.1016/j.leukres.2011.03.025

PMID:21489623

Abstract

摘要

相似文献

NUP214-ABL1 positive T-cell acute lymphoblastic leukemia patient shows an initial favorable response to imatinib therapy post relapse.NUP214-ABL1阳性T细胞急性淋巴细胞白血病患者复发后对伊马替尼治疗显示出初步良好反应。

Leuk Res. 2011 Jul;35(7):e131-3. doi: 10.1016/j.leukres.2011.03.025. Epub 2011 Apr 13.

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia.T细胞急性淋巴细胞白血病中扩增附加体上NUP214与ABL1的融合

Nat Genet. 2004 Oct;36(10):1084-9. doi: 10.1038/ng1425. Epub 2004 Sep 12.

Complete morphologic and molecular remission after introduction of dasatinib in the treatment of a pediatric patient with t-cell acute lymphoblastic leukemia and ABL1 amplification.达沙替尼治疗伴有 ABL1 扩增的儿童 T 细胞急性淋巴细胞白血病患者，实现完全形态学和分子学缓解。

Pediatr Blood Cancer. 2012 Aug;59(2):333-4. doi: 10.1002/pbc.23327. Epub 2012 Jan 3.

ABL1 rearrangements in T-cell acute lymphoblastic leukemia.T 细胞急性淋巴细胞白血病中的 ABL1 重排。

Genes Chromosomes Cancer. 2010 Apr;49(4):299-308. doi: 10.1002/gcc.20743.

Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukemia.在BCR-ABL阳性急性淋巴细胞白血病中，增加BCR-ABL表达水平和/或ABL点突变的出现并不总是能预测对甲磺酸伊马替尼的耐药性。

Leuk Res. 2009 Jul;33(7):e73-4. doi: 10.1016/j.leukres.2008.11.009. Epub 2008 Dec 23.

Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.单中心300例接受伊马替尼治疗的BCR-ABL阳性白血病患者的反应与耐药情况：4.5年随访

Cancer. 2005 Apr 15;103(8):1659-69. doi: 10.1002/cncr.20922.

Detection of a cryptic gene fusion by mate-pair sequencing (MPseq) in a newly diagnosed case of pediatric T-lymphoblastic leukemia.在一例新诊断的儿童T淋巴细胞白血病病例中，通过配对末端测序（MPseq）检测到一个隐匿性基因融合。

Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2). doi: 10.1101/mcs.a003533. Print 2019 Apr.

T-cell acute lymphoblastic leukemia associated with complex karyotype and SET-NUP214 rearrangement: a case study and review of the literature.伴有复杂核型和SET-NUP214重排的T细胞急性淋巴细胞白血病：病例报告及文献复习

Ann Clin Lab Sci. 2011 Summer;41(3):267-72.

NUP214-ABL1 in adult T-ALL: the GMALL study group experience.成人T细胞急性淋巴细胞白血病中的NUP214-ABL1：GMALL研究组的经验

Blood. 2006 Nov 15;108(10):3556-9. doi: 10.1182/blood-2006-04-014514. Epub 2006 Jul 27.

Fusion of NUP214 to ABL1 on amplified episomes in T-ALL--implications for treatment.T 细胞急性淋巴细胞白血病中 NUP214 与 ABL1 在扩增附加体上的融合——对治疗的启示

Leukemia. 2005 Sep;19(9):1680-1. doi: 10.1038/sj.leu.2403877.

引用本文的文献

fusion genes in acute leukemias: genetic characterization of rare cases.急性白血病中的融合基因：罕见病例的遗传学特征

Front Oncol. 2024 Mar 20;14:1371980. doi: 10.3389/fonc.2024.1371980. eCollection 2024.

Current perspectives in T-ALL.T 细胞急性淋巴细胞白血病的当前观点

Hemasphere. 2019 Jun 30;3(Suppl). doi: 10.1097/HS9.0000000000000259. eCollection 2019 Jun.

Case Report: The First Report of Fusion Gene in Acute Myeloid Leukemia Patient Detected by Next-Generation Sequencing.病例报告：通过下一代测序检测到的急性髓系白血病患者融合基因的首例报告。

Front Oncol. 2021 Jul 8;11:706798. doi: 10.3389/fonc.2021.706798. eCollection 2021.

The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia.T 细胞急性淋巴细胞白血病的遗传学和机制。

Cold Spring Harb Perspect Med. 2020 Mar 2;10(3):a035246. doi: 10.1101/cshperspect.a035246.

Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2). doi: 10.1101/mcs.a003533. Print 2019 Apr.

Relapsed T Cell ALL: Current Approaches and New Directions.复发性T细胞急性淋巴细胞白血病：当前方法与新方向

Curr Hematol Malig Rep. 2019 Apr;14(2):83-93. doi: 10.1007/s11899-019-00501-3.

Can one target T-cell ALL?能否靶向T细胞急性淋巴细胞白血病？

Best Pract Res Clin Haematol. 2018 Dec;31(4):361-366. doi: 10.1016/j.beha.2018.10.001. Epub 2018 Oct 17.

Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.TLX1 和 STAT5 通过协同增强子激活驱动 NUP214-ABL1/TLX1-阳性 T 细胞急性淋巴细胞白血病的发生。

Cancer Cell. 2018 Aug 13;34(2):271-285.e7. doi: 10.1016/j.ccell.2018.07.007.

Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia.1例T细胞急性淋巴细胞白血病中BCR-ABL1基因融合的独特扩增

Mol Cytogenet. 2017 Oct 26;10:39. doi: 10.1186/s13039-017-0340-6. eCollection 2017.

Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia.靶向PI3K/AKT/mTOR通路或NUP214-ABL1融合蛋白的选择性抑制剂在人类急性淋巴细胞白血病中的协同作用

Oncotarget. 2016 Nov 29;7(48):79842-79853. doi: 10.18632/oncotarget.13035.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验